Illumina Inc stock page - price, fundamentals, dividends - iOCharts

Ticker
ILMN

Price
191.04
Stock movement up
+6.68 (3.62%)
Company name
Illumina Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Diagnostics & Research
Market cap
30.01B
Ent value
33.04B
Price/Sales
6.45
Price/Book
2.57
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
42.87
Forward P/E
36.67
PEG
3.15
EPS growth
23.20%
1 year return
-59.41%
3 year return
-19.87%
5 year return
1.57%
10 year return
17.17%
Last updated: 2022-07-01

DIVIDENDS

ILMN does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E42.87
Price to OCF68.99
Price to FCF144.29
Price to EBITDA25.09
EV to EBITDA27.63

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales6.45
Price to Book2.57
EV to Sales7.10

FINANCIALS

Per share

Loading...
Per share data
Current share count157.10M
EPS (TTM)8.71
FCF per share (TTM)2.59

Income statement

Loading...
Income statement data
Revenue (TTM)4.66B
Gross profit (TTM)3.20B
Operating income (TTM)-133.00M
Net income (TTM)700.00M
EPS (TTM)8.71
EPS (1y forward)5.21

Margins

Loading...
Margins data
Gross margin (TTM)68.81%
Operating margin (TTM)-2.86%
Profit margin (TTM)15.03%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.35B
Net receivables614.00M
Total current assets2.75B
Goodwill7.11B
Intangible assets3.21B
Property, plant and equipment0.00
Total assets15.27B
Accounts payable291.00M
Short/Current long term debt2.62B
Total current liabilities1.49B
Total liabilities4.38B
Shareholder's equity11.70B
Net tangible assets1.38B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)435.00M
Capital expenditures (TTM)227.00M
Free cash flow (TTM)208.00M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity5.98%
Return on Assets4.58%
Return on Invested Capital5.21%
Cash Return on Invested Capital1.55%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open183.35
Daily high191.25
Daily low183.19
Daily Volume1.09M
All-time high524.84
1y analyst estimate349.19
Beta1.00
EPS (TTM)8.71
Dividend per share-
Ex-div date-
Next earnings date3 Aug 2022

Downside potential

Loading...
Downside potential data
ILMNS&P500
Current price drop from All-time high-63.60%-20.19%
Highest price drop-96.14%-56.47%
Date of highest drop13 Mar 20039 Mar 2009
Avg drop from high-34.72%-11.36%
Avg time to new high24 days12 days
Max time to new high1731 days1805 days
COMPANY DETAILS
ILMN (Illumina Inc) company logo
Marketcap
30.01B
Marketcap category
Large-cap
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Employees
9800
SEC filings
CEO
Francis deSouza
Country
USA
City
San Diego
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Illumina and Cold Spring Harbor Asia DNA Learning Center reach more than 1,000 STEM learners through a new program
July 1, 2022
S&P 500 stocks have been a mixed bag at best this year. During the week of June 21, I think the market began to accept the idea that a ” soft landing” by the economy is much more likely than a “hard l...
June 30, 2022
Illumina's (ILMN) division GRAIL will offer the Galleri MCED blood test to eligible patients across the Community Health Network's care sites.
June 29, 2022
Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates
June 29, 2022
How one St. Louis company is using sequencing to identify microbes that naturally control pests and boost agricultural yields
June 28, 2022
MENLO PARK, Calif. & INDIANAPOLIS, June 28, 2022--GRAIL and Community Health Network partner to offer Galleri® to individuals at Community Health Network’s sites of care.
June 28, 2022
Illumina (ILMN) closed the most recent trading day at $193.93, moving +0.2% from the previous trading session.
June 24, 2022
Public/private partnership expands access to comprehensive genomic profiling to improve patient care and advance drug discovery
June 24, 2022
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of a research test, codeveloped with Merck (known as MSD outside the United St...
June 22, 2022
How artificial intelligence and automation are enabling precision medicine to become the standard of care
June 14, 2022
Next page